Skip to main content
Erschienen in: Journal of Assisted Reproduction and Genetics 10/2013

01.10.2013 | Assisted Reproduction Technologies

“Follicular HCG endometrium priming for IVF patients experiencing resisting thin endometrium. A proof of concept study”

verfasst von: E. G. Papanikolaou, D. Kyrou, G. Zervakakou, Efstathia Paggou, P. Humaidan

Erschienen in: Journal of Assisted Reproduction and Genetics | Ausgabe 10/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

A thin endometrium is one of the most difficult problems encountered in assisted reproduction every day practice. Whether a daily dose of 150 IU HCG for 7 days concomitant with estrogen administration in estrogen replacement cycles can increase the endometrial thickness and improve pregnancy outcome, was the objective of the current study.

Methods

Seventeen infertile patients with successive implantation failures and resisting thin endometrium, being recipients of fresh donor or frozen embryos were recruited. This was a prospective cohort, proof of concept study, NCT01768247. On day-8 or 9 of the estrogen administration, and continuing 8 mg estrogen per day, subcutaneous injections of 150 IU HCG were initiated daily for 7 days. After a week on HCG priming, (day-14 or 15) endometrial thickness was controlled with ultrasound, and progesterone was initiated.

Results

Mean endometrial thickness was increased from 5.2 mm to 6 mm (p = 0.008). 35.3 % of the patients had more than 20 % improvement of their endometrial thickness after HCG priming. 17 % achieved an endometrial thickness more than 7 mm, and 29.4 % did not improve their thickness at all. Interestingly, from the later two became pregnant. Overall, 41 % of them (7/17) finally delivered.

Conclusions

One hundred fifty IU HCG endometrial priming for 7 days in the proliferative phase of estrogen substituted cycles for frozen embryos is highly promising, as not only the thickness of the endometrium improves but also eventually the receptivity appears normalized.
Literatur
1.
Zurück zum Zitat Andersen AN, Devroey P, Arce JC. Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial. Hum Reprod. 2006;21:3217–27.PubMedCrossRef Andersen AN, Devroey P, Arce JC. Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial. Hum Reprod. 2006;21:3217–27.PubMedCrossRef
2.
Zurück zum Zitat Bourdiec A, Shao R, Rao CV, Akoum A. human chorionic gonadotropin triggers angiogenesis via the modulation of endometrial stromal cell responsiveness to interleukin 1: a new possible mechanism underlying embryo implantation. Biol Reprod. 2012;87:66.PubMedCrossRef Bourdiec A, Shao R, Rao CV, Akoum A. human chorionic gonadotropin triggers angiogenesis via the modulation of endometrial stromal cell responsiveness to interleukin 1: a new possible mechanism underlying embryo implantation. Biol Reprod. 2012;87:66.PubMedCrossRef
3.
Zurück zum Zitat Bourgain C, Devroey P. Histologic and functional aspects of the endometrium in the implantatory phase. Gynecol Obstet Invest. 2007;64:131–3.PubMedCrossRef Bourgain C, Devroey P. Histologic and functional aspects of the endometrium in the implantatory phase. Gynecol Obstet Invest. 2007;64:131–3.PubMedCrossRef
4.
Zurück zum Zitat Check JH, Graziano V, Lee G, Nazari A, Choe JK, Dietterich C. Neither sildenafil nor vaginal estradiol improves endometrial thickness in women with thin endometria after taking oral estradiol in graduating dosages. Clin Exp Obstet Gynecol. 2004;31:99–102.PubMed Check JH, Graziano V, Lee G, Nazari A, Choe JK, Dietterich C. Neither sildenafil nor vaginal estradiol improves endometrial thickness in women with thin endometria after taking oral estradiol in graduating dosages. Clin Exp Obstet Gynecol. 2004;31:99–102.PubMed
5.
Zurück zum Zitat Chen MJ, Yang JH, Peng FH, Chen SU, Ho HN, Yang YS. Extended estrogen administration for women with thin endometrium in frozen-thawed in-vitro fertilization programs. J Assist Reprod Genet. 2006;23:337–4.PubMedCrossRef Chen MJ, Yang JH, Peng FH, Chen SU, Ho HN, Yang YS. Extended estrogen administration for women with thin endometrium in frozen-thawed in-vitro fertilization programs. J Assist Reprod Genet. 2006;23:337–4.PubMedCrossRef
6.
Zurück zum Zitat Cicek N, Eryilmaz OG, Sarikaya E, Gulerman C, Genc Y. Vitamin E effect on controlled ovarian stimulation of unexplained infertile women. J Assist Reprod Genet. 2012;29:325–8.PubMedCrossRef Cicek N, Eryilmaz OG, Sarikaya E, Gulerman C, Genc Y. Vitamin E effect on controlled ovarian stimulation of unexplained infertile women. J Assist Reprod Genet. 2012;29:325–8.PubMedCrossRef
7.
Zurück zum Zitat Detti L, Yelian FD, Kruger ML, Diamond MP, Puscheck EE. Endometrial thickness dynamics and morphologic characteristics during pituitary downregulation with antagonists in assisted reproductive technology cycles. J Ultrasound Med. 2008;27:1591–6.PubMed Detti L, Yelian FD, Kruger ML, Diamond MP, Puscheck EE. Endometrial thickness dynamics and morphologic characteristics during pituitary downregulation with antagonists in assisted reproductive technology cycles. J Ultrasound Med. 2008;27:1591–6.PubMed
8.
Zurück zum Zitat Dix E, Check JH. Successful pregnancies following embryo transfer despite very thin late proliferative endometrium. Clin Exp Obstet Gynecol. 2010;37:15–6.PubMed Dix E, Check JH. Successful pregnancies following embryo transfer despite very thin late proliferative endometrium. Clin Exp Obstet Gynecol. 2010;37:15–6.PubMed
9.
Zurück zum Zitat Elizur SE, Son WY, Yap R, Gidoni Y, Levin D, Demirtas E, et al. Comparison of low-dose human menopausal gonadotropin and micronized 17beta-estradiol supplementation in in-vitro maturation cycles with thin endometrial lining. Fertil Steril. 2009;92:907–12.PubMedCrossRef Elizur SE, Son WY, Yap R, Gidoni Y, Levin D, Demirtas E, et al. Comparison of low-dose human menopausal gonadotropin and micronized 17beta-estradiol supplementation in in-vitro maturation cycles with thin endometrial lining. Fertil Steril. 2009;92:907–12.PubMedCrossRef
10.
Zurück zum Zitat Fatemi HM, Popovic-Todorovic B, Papanikolaou E, Donoso P, Devroey P. An update of luteal phase support in stimulated IVF cycles. Hum Reprod Update. 2007;13:581–90.PubMedCrossRef Fatemi HM, Popovic-Todorovic B, Papanikolaou E, Donoso P, Devroey P. An update of luteal phase support in stimulated IVF cycles. Hum Reprod Update. 2007;13:581–90.PubMedCrossRef
11.
Zurück zum Zitat Gleicher N, Vidali A, Barad DH. Successful treatment of unresponsive thin endometrium. Fertil Steril. 2011;95:2123.PubMedCrossRef Gleicher N, Vidali A, Barad DH. Successful treatment of unresponsive thin endometrium. Fertil Steril. 2011;95:2123.PubMedCrossRef
12.
Zurück zum Zitat Licht P, Russu V, Lehmeyer S, Wildt L. Molecular aspects of direct LH/hCG effects on human endometrium–lessons from intrauterine microdialysis in the human female in vivo. Reprod Biol. 2001;1:10–9.PubMed Licht P, Russu V, Lehmeyer S, Wildt L. Molecular aspects of direct LH/hCG effects on human endometrium–lessons from intrauterine microdialysis in the human female in vivo. Reprod Biol. 2001;1:10–9.PubMed
13.
Zurück zum Zitat Licht P, von Wolff M, Berkholz A, Wildt L. Evidence for cycle-dependent expression of full-length human chorionic gonadotropin/luteinizing hormone receptor mRNA in human endometrium and decidua. Fertil Steril. 2003;79 Suppl 1:718–23.PubMedCrossRef Licht P, von Wolff M, Berkholz A, Wildt L. Evidence for cycle-dependent expression of full-length human chorionic gonadotropin/luteinizing hormone receptor mRNA in human endometrium and decidua. Fertil Steril. 2003;79 Suppl 1:718–23.PubMedCrossRef
14.
Zurück zum Zitat Prapas N, Tavaniotou A, Panagiotidis Y, Prapa S, Kasapi E, Goudakou M, et al. Low-dose human chorionic gonadotropin during the proliferative phase may adversely affect endometrial receptivity in oocyte recipients. Gynecol Endocrinol. 2009;25:53–9.PubMedCrossRef Prapas N, Tavaniotou A, Panagiotidis Y, Prapa S, Kasapi E, Goudakou M, et al. Low-dose human chorionic gonadotropin during the proliferative phase may adversely affect endometrial receptivity in oocyte recipients. Gynecol Endocrinol. 2009;25:53–9.PubMedCrossRef
15.
Zurück zum Zitat Reshef E, Lei ZM, Rao CV, Pridham DD, Chegini N, Luborsky JL. The presence of gonadotropin receptors in nonpregnant human uterus, human placenta, fetal membranes, and decidua. J Clin Endocrinol Metab. 1990;70:421–30.PubMedCrossRef Reshef E, Lei ZM, Rao CV, Pridham DD, Chegini N, Luborsky JL. The presence of gonadotropin receptors in nonpregnant human uterus, human placenta, fetal membranes, and decidua. J Clin Endocrinol Metab. 1990;70:421–30.PubMedCrossRef
16.
Zurück zum Zitat Saha TK, Amer SA, Biss J, Thakare H, Williams S, Farrell CT, et al. The validity of transvaginal ultrasound measurement of endometrial thickness: a comparison of ultrasound measurement with direct anatomical measurement. BJOG. 2004;111:1419–24.PubMedCrossRef Saha TK, Amer SA, Biss J, Thakare H, Williams S, Farrell CT, et al. The validity of transvaginal ultrasound measurement of endometrial thickness: a comparison of ultrasound measurement with direct anatomical measurement. BJOG. 2004;111:1419–24.PubMedCrossRef
17.
Zurück zum Zitat Senturk LM, Erel CT. Thin endometrium in assisted reproductive technology. Curr Opin Obstet Gynecol. 2008;20:221–8.PubMedCrossRef Senturk LM, Erel CT. Thin endometrium in assisted reproductive technology. Curr Opin Obstet Gynecol. 2008;20:221–8.PubMedCrossRef
18.
Zurück zum Zitat Sher G, Herbert C, Maassarani G, Jacobs MH. Assessment of the late proliferative phase endometrium by ultrasonography in patients undergoing in-vitro fertilization and embryo transfer (IVF/ET). Hum Reprod. 1991;6:232–7.PubMed Sher G, Herbert C, Maassarani G, Jacobs MH. Assessment of the late proliferative phase endometrium by ultrasonography in patients undergoing in-vitro fertilization and embryo transfer (IVF/ET). Hum Reprod. 1991;6:232–7.PubMed
19.
Zurück zum Zitat Shufaro Y, Simon A, Fatum M. Thin unresponsive endometrium—a possible complication of surgical curettage compromising ART outcome. J Assist Reprod Genet. 2008;25:421–5.PubMedCrossRef Shufaro Y, Simon A, Fatum M. Thin unresponsive endometrium—a possible complication of surgical curettage compromising ART outcome. J Assist Reprod Genet. 2008;25:421–5.PubMedCrossRef
20.
Zurück zum Zitat Zenke U, Chetkowski RJ. Transfer and uterine factors are the major recipient-related determinants of success with donor eggs. Fertil Steril. 2004;82:850.PubMedCrossRef Zenke U, Chetkowski RJ. Transfer and uterine factors are the major recipient-related determinants of success with donor eggs. Fertil Steril. 2004;82:850.PubMedCrossRef
21.
Zurück zum Zitat Zhu W, Chen M, Liu J, Fu Z, Li X, Qin C, et al. Receptivity assessment of an ultrasonographic homogeneous endometrium in the late follicular phase of infertile women with natural cycles. Am J Obstet Gynecol. 2012;207:511–7.PubMedCrossRef Zhu W, Chen M, Liu J, Fu Z, Li X, Qin C, et al. Receptivity assessment of an ultrasonographic homogeneous endometrium in the late follicular phase of infertile women with natural cycles. Am J Obstet Gynecol. 2012;207:511–7.PubMedCrossRef
Metadaten
Titel
“Follicular HCG endometrium priming for IVF patients experiencing resisting thin endometrium. A proof of concept study”
verfasst von
E. G. Papanikolaou
D. Kyrou
G. Zervakakou
Efstathia Paggou
P. Humaidan
Publikationsdatum
01.10.2013
Verlag
Springer US
Erschienen in
Journal of Assisted Reproduction and Genetics / Ausgabe 10/2013
Print ISSN: 1058-0468
Elektronische ISSN: 1573-7330
DOI
https://doi.org/10.1007/s10815-013-0076-0

Weitere Artikel der Ausgabe 10/2013

Journal of Assisted Reproduction and Genetics 10/2013 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.